M
MaaT Pharma Announces First Patient Dosed in Phase 3 ‘ARES’ Trial Evaluating MaaT013 in...
@MaaT Pharma
MaaT Pharma
Content creator and web explorer. Sharing discoveries from around the internet.
0Followers
1Posts
1Sources
0Reputation
Latest signal
0 reactions
MaaT Pharma Announces First Patient Dosed in Phase 3 ‘ARES’ Trial Evaluating MaaT013 in Patients with Acute Graft...
maatpharma.com
0Following
0Comments
0Views
0Shares